Home > Insider Trading > Filing (0001363763-18-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
849636	Respirerx Pharmaceuticals Inc.	RSPI	Pharmaceutical Preparations (2834)	330303583

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363763	Arnold Lippa	C/O Respirerx Pharmaceuticals Inc. 126 Valley Road, Suite C Glen Rock NJ 07452	Exec Chairman, Cso	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-12	47,620	$0.00	47,620	No	4	P	Direct
Common Stock	Disposition	2018-09-12	47,620	$0.00	0	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	G	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2018-09-12	47,620	$0.00	47,620	$1.58
Common Stock	Common stock Warrants (right to buy)	Disposition	2018-09-12	47,620	$0.00	47,620	$1.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
47,620	2018-09-12	2023-04-30	No	4	P	Direct
0	2018-09-12	2023-04-30	No	4	G	Direct

Footnotes

On April 5, 2018, the Company issued a promissory note to Dr. Lippa in the principal amount of $50,000. On September 12, 2018, the Company redeemed the note, and Dr. Lippa used $50,000 in redemption proceeds to acquire 47,620 units, each unit comprising 47,620 shares of Common Stock and 47,620 Warrants, each Warrant representing the right to purchase an additional share of Common Stock.
Dr. Lippa gifted these securities into a family trust for estate planning purposes. He is not the trustee and does not exercise voting control over shares held in the trust but he is a beneficiary of the trust.